Basal cell carcinoma of skin of upper limb, including shoulder
ICD-10 C44.61 is a billable code used to indicate a diagnosis of basal cell carcinoma of skin of upper limb, including shoulder.
Basal cell carcinoma (BCC) is the most common form of skin cancer, arising from the basal cells in the epidermis. This malignancy is primarily associated with chronic sun exposure, leading to DNA damage in skin cells. BCCs typically present as pearly nodules, flat lesions, or scaly patches on sun-exposed areas, including the upper limb and shoulder. The risk factors for developing BCC include fair skin, a history of sunburns, and prolonged UV exposure. Surgical excision is the most common treatment, with the goal of achieving clear surgical margins to minimize recurrence. Reconstruction may be necessary depending on the size and location of the excised lesion, particularly in cosmetically sensitive areas. The prognosis for BCC is generally favorable, with a low risk of metastasis, but careful monitoring is essential due to the potential for local recurrence and the development of new skin cancers.
Detailed descriptions of the lesion, treatment plans, and follow-up care.
Diagnosis and treatment of BCC, Mohs micrographic surgery, and post-operative care.
Ensure accurate documentation of margins and any additional procedures performed.
Comprehensive treatment history, including chemotherapy or radiation if applicable.
Management of recurrent BCC or BCC in immunocompromised patients.
Document any systemic therapies or clinical trials involved in treatment.
Used when excising a BCC from the upper limb.
Document the size of the lesion and margins obtained.
Dermatologists should ensure clear documentation of the procedure and follow-up care.
The primary cause of basal cell carcinoma is prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds, which leads to DNA damage in skin cells.
